Specific G(q) protein involvement in muscarinic M-3 receptor-induced phosphatidylinositol hydrolysis and Ca2+ release in mouse duodenal myocytes

被引:30
作者
Morel, JL [1 ]
Macrez, N [1 ]
Mironneau, J [1 ]
机构
[1] UNIV BORDEAUX 2,LAB PHYSIOL CELLULAIRE & PHARMACOL MOL,CNRS,ESA 5017,F-33076 BORDEAUX,FRANCE
关键词
duodenal smooth muscle cells; Ca2+ release; muscarinic receptors; G protein; phosphatidylinositol - phospholipase C;
D O I
10.1038/sj.bjp.0701157
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Cytosolic Ca2+ concentration ([Ca2+](i)) during exposure to acetylcholine or caffeine was measured in mouse duodenal myocytes loaded with fura-2. Acetylcholine evoked a transient increase in [Ca2+](i) followed by a sustained rise which was rapidly terminated after drug removal. Although L-type Ca2+ currents participated in the global Ca2+ response induced by acetylcholine, the initial peak in [Ca2+](i) was mainly due to release of Ca2+ from intracellular stores. 2 Atropine, 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, a muscarinic M-3 antagonist), pirenzepine (a muscarinic M-1 antagonist), methoctramine and gallamine (muscarinic M-2 antagonists) inhibited the acetylcholine-induced Ca2+ release, with a high affinity for 4-DAMP and atropine and a low affinity for the other antagonists. Selective protection of muscarinic M-2 receptors with methoctramine during 4-DAMP mustard alkylation of muscarinic M-3 receptors provided no evidence for muscarinic M-2 receptor-activated [Ca2+](i) increase. 3 Acetylcholine-induced Ca2+ release was blocked by intracellular dialysis with a patch pipette containing either heparin or an anti-phosphatidylinositol antibody and by external application of U73122 (a phospholipase C inhibitor). 4 Acetylcholine-induced Ca2+ release was insensitive to external pretreatment with pertussis toxin, but concentration-dependently inhibited by intracellular dialysis with a patch pipette solution containing an anti-alpha(q)/alpha(11) antibody. An antisense oligonucleotide approach revealed that only the G(q) protein was involved in acetylcholine-induced Ca2+ release. 5 Intracellular applications of either an anti-beta(com) antibody or a peptide corresponding to the G beta gamma binding domain of the beta-adrenoceptor kinase 1 had no effect on acetylcholine-induced Ca2+ release. 6 Our results show that, in mouse duodenal myocytes, acetylcholine-induced release of Ca2+ from intracellular stores is mediated through activation of muscarinic M-3 receptors which couple with a G(q) protein to activate a phosphatidylinositol-specific phospholipase C.
引用
收藏
页码:451 / 458
页数:8
相关论文
共 34 条
[1]  
ARAGAY AM, 1992, J BIOL CHEM, V267, P24983
[2]   ACETYLCHOLINE ANALOG STIMULATES DNA-SYNTHESIS IN BRAIN-DERIVED CELLS VIA SPECIFIC MUSCARINIC RECEPTOR SUBTYPES [J].
ASHKENAZI, A ;
RAMACHANDRAN, J ;
CAPON, DJ .
NATURE, 1989, 340 (6229) :146-150
[3]  
BAUMGOLD J, 1995, CELL SIGNAL, V793, P39
[4]  
BLITZER RD, 1993, J BIOL CHEM, V268, P7532
[5]   ISOZYME-SELECTIVE STIMULATION OF PHOSPHOLIPASE C-BETA-2 BY G-PROTEIN BETA-GAMMA-SUBUNITS [J].
CAMPS, M ;
CAROZZI, A ;
SCHNABEL, P ;
SCHEER, A ;
PARKER, PJ ;
GIERSCHIK, P .
NATURE, 1992, 360 (6405) :684-686
[6]   G(S) COUPLES THYROTROPIN-RELEASING-HORMONE RECEPTORS EXPRESSED IN XENOPUS OOCYTES TO PHOSPHOLIPASE-C [J].
DELAPENA, P ;
DELCAMINO, D ;
PARDO, LA ;
DOMINGUEZ, P ;
BARROS, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :3554-3559
[7]  
DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676
[8]   A heterotrimeric G protein complex couples the muscarinic m1 receptor to phospholipase C-beta [J].
Dippel, E ;
Kalkbrenner, F ;
Wittig, B ;
Schultz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1391-1396
[9]   PHARMACOLOGICAL PROFILE OF SELECTIVE MUSCARINIC RECEPTOR ANTAGONISTS ON GUINEA-PIG ILEAL SMOOTH-MUSCLE [J].
DOODS, HN ;
ENTZEROTH, M ;
ZIEGLER, H ;
MAYER, N ;
HOLZER, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 253 (03) :275-281
[10]   CHARACTERIZATION OF MUSCARINIC RECEPTORS IN GUINEA-PIG UTERUS [J].
DOODS, HN ;
WILLIM, KD ;
BODDEKE, HWGM ;
ENTZEROTH, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (02) :223-230